114 related articles for article (PubMed ID: 8564395)
1. Conjugation of doxorubicin to monoclonal anti-carcinoembryonic antigen antibody via novel thiol-directed cross-linking reagents.
Lau A; Bérubé G; Ford CH
Bioorg Med Chem; 1995 Oct; 3(10):1299-304. PubMed ID: 8564395
[TBL] [Abstract][Full Text] [Related]
2. Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro.
Lau A; Bérubé G; Ford CH; Gallant M
Bioorg Med Chem; 1995 Oct; 3(10):1305-12. PubMed ID: 8564396
[TBL] [Abstract][Full Text] [Related]
3. A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates.
Zara JJ; Wood RD; Boon P; Kim CH; Pomato N; Bredehorst R; Vogel CW
Anal Biochem; 1991 Apr; 194(1):156-62. PubMed ID: 1867379
[TBL] [Abstract][Full Text] [Related]
4. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
Willner D; Trail PA; Hofstead SJ; King HD; Lasch SJ; Braslawsky GR; Greenfield RS; Kaneko T; Firestone RA
Bioconjug Chem; 1993; 4(6):521-7. PubMed ID: 7508268
[TBL] [Abstract][Full Text] [Related]
5. Interaction analysis of the carcinoembryonic antigen (CEA) with its monoclonal antibody immobilized on a gold surface using Fourier transform infrared reflection-absorption spectroscopy (FT-IR RAS).
Ohtsuka K; Kuroki M; Nojima T; Waki M; Takenaka S
Anal Sci; 2005 Mar; 21(3):215-8. PubMed ID: 15790101
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
Sinkule JA; Rosen ST; Radosevich JA
Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen.
Stan AC; Radu DL; Casares S; Bona CA; Brumeanu TD
Cancer Res; 1999 Jan; 59(1):115-21. PubMed ID: 9892195
[TBL] [Abstract][Full Text] [Related]
8. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
Lewis MR; Shively JE
Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
[TBL] [Abstract][Full Text] [Related]
9. Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo.
Ma Z; He H; Sun F; Xu Y; Huang X; Ma Y; Zhao H; Wang Y; Wang M; Zhang J
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1929-1940. PubMed ID: 28536738
[TBL] [Abstract][Full Text] [Related]
10. Internalization of an intact doxorubicin immunoconjugate.
Shih LB; Goldenberg DM; Xuan H; Lu HW; Mattes MJ; Hall TC
Cancer Immunol Immunother; 1994 Feb; 38(2):92-8. PubMed ID: 8306371
[TBL] [Abstract][Full Text] [Related]
11. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
[TBL] [Abstract][Full Text] [Related]
12. New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.
Kaneko T; Willner D; Monkovíc I; Knipe JO; Braslawsky GR; Greenfield RS; Vyas DM
Bioconjug Chem; 1991; 2(3):133-41. PubMed ID: 1932212
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.
Byers VS; Pawluczyk I; Berry N; Durrant L; Robins RA; Garnett MC; Price MR; Baldwin RW
J Immunol; 1988 Jun; 140(11):4050-5. PubMed ID: 2453564
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-anti-carcinoembryonic antigen immunoconjugate activity in vitro.
Richardson VJ; Ford CH; Tsaltas G; Gallant ME
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):633-40. PubMed ID: 2714340
[TBL] [Abstract][Full Text] [Related]
15. Preparation of immunoconjugates using antibody oligosaccharide moieties.
Vogel CW
Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
[TBL] [Abstract][Full Text] [Related]
16. N-terminal modification of immunoglobulin polypeptide chains tagged with isothiocyanato chelates.
Rana TM; Meares CF
Bioconjug Chem; 1990; 1(5):357-62. PubMed ID: 2129106
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of chimeric BR96-doxorubicin immunoconjugate.
Barbour NP; Paborji M; Alexander TC; Coppola WP; Bogardus JB
Pharm Res; 1995 Feb; 12(2):215-22. PubMed ID: 7784336
[TBL] [Abstract][Full Text] [Related]
18. Antibody-toxin conjugation.
Marsh JW; Srinivasachar K; Neville DM
Cancer Treat Res; 1988; 37():213-37. PubMed ID: 2908626
[No Abstract] [Full Text] [Related]
19. Toxin-targeted design for anticancer therapy. II: Preparation and biological comparison of different chemically linked gelonin-antibody conjugates.
Delprino L; Giacomotti M; Dosio F; Brusa P; Ceruti M; Grosa G; Cattel L
J Pharm Sci; 1993 Jul; 82(7):699-704. PubMed ID: 8360843
[TBL] [Abstract][Full Text] [Related]
20. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
